英国人类微生物组在健康和疾病中的作用

Amelia Wesley
{"title":"英国人类微生物组在健康和疾病中的作用","authors":"Amelia Wesley","doi":"10.47604/ijns.2177","DOIUrl":null,"url":null,"abstract":"Purpose: The aim of the study was to investigate the role of the human microbiome in health and disease in United Kingdom.
 Methodology: The study adopted a desktop methodology. Desk research refers to secondary data or that which can be collected without fieldwork. Desk research is basically involved in collecting data from existing resources hence it is often considered a low cost technique as compared to field research, as the main cost is involved in executive’s time, telephone charges and directories. Thus, the study relied on already published studies, reports and statistics. This secondary data was easily accessed through the online journals and library
 Findings: The microbiome influences human health and disease by providing essential functions, such as nutrient metabolism, immune regulation, and protection against pathogens. However, the microbiome can also be disrupted by various factors, such as diet, lifestyle, age, genetics, and infections, leading to dysbiosis and increased risk of diseases. In the United Kingdom, research on the microbiome has been conducted to understand its role in various conditions, such as obesity, diabetes, inflammatory bowel disease, cancer, and mental health. The findings suggest that modulating the microbiome through dietary interventions, probiotics, prebiotics, or fecal microbiota transplantation may offer novel strategies for preventing or treating these diseases.
 Unique Contribution to Theory, Practice and Policy: Microbiome Dysbiosis Theory, Hygiene Hypothesis Theory and Microbiota-Brain-Gut Axis Theory may be used to anchor future studies on role of the human microbiome in health and disease in United Kingdom. Findings can invest in the development of microbiome-based therapeutics, including fecal microbiota transplantation (FMT), engineered probiotics, and microbial-derived products. Policymakers should establish a regulatory framework for microbiome-based interventions, ensuring their safety, efficacy, and accessibility.","PeriodicalId":488386,"journal":{"name":"International Journal of Natural Sciences","volume":"181 6","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Role of the Human Microbiome in Health and Disease in United Kingdom\",\"authors\":\"Amelia Wesley\",\"doi\":\"10.47604/ijns.2177\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Purpose: The aim of the study was to investigate the role of the human microbiome in health and disease in United Kingdom.
 Methodology: The study adopted a desktop methodology. Desk research refers to secondary data or that which can be collected without fieldwork. Desk research is basically involved in collecting data from existing resources hence it is often considered a low cost technique as compared to field research, as the main cost is involved in executive’s time, telephone charges and directories. Thus, the study relied on already published studies, reports and statistics. This secondary data was easily accessed through the online journals and library
 Findings: The microbiome influences human health and disease by providing essential functions, such as nutrient metabolism, immune regulation, and protection against pathogens. However, the microbiome can also be disrupted by various factors, such as diet, lifestyle, age, genetics, and infections, leading to dysbiosis and increased risk of diseases. In the United Kingdom, research on the microbiome has been conducted to understand its role in various conditions, such as obesity, diabetes, inflammatory bowel disease, cancer, and mental health. The findings suggest that modulating the microbiome through dietary interventions, probiotics, prebiotics, or fecal microbiota transplantation may offer novel strategies for preventing or treating these diseases.
 Unique Contribution to Theory, Practice and Policy: Microbiome Dysbiosis Theory, Hygiene Hypothesis Theory and Microbiota-Brain-Gut Axis Theory may be used to anchor future studies on role of the human microbiome in health and disease in United Kingdom. Findings can invest in the development of microbiome-based therapeutics, including fecal microbiota transplantation (FMT), engineered probiotics, and microbial-derived products. Policymakers should establish a regulatory framework for microbiome-based interventions, ensuring their safety, efficacy, and accessibility.\",\"PeriodicalId\":488386,\"journal\":{\"name\":\"International Journal of Natural Sciences\",\"volume\":\"181 6\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Natural Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47604/ijns.2177\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Natural Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47604/ijns.2177","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的:本研究的目的是调查英国人类微生物组在健康和疾病中的作用。方法学:本研究采用桌面方法学。案头研究指的是二手数据或不需要实地调查就能收集到的数据。案头调查基本上涉及从现有资源中收集数据,因此,与实地调查相比,案头调查通常被认为是一种成本较低的技术,因为主要费用是行政人员的时间、电话费和通讯录。因此,这项研究依赖于已经发表的研究、报告和统计数据。这些辅助数据很容易通过在线期刊和图书馆获得 研究结果:微生物组通过提供必要的功能,如营养代谢、免疫调节和对病原体的保护,影响人类健康和疾病。然而,微生物组也可能受到各种因素的破坏,如饮食、生活方式、年龄、遗传和感染,导致生态失调和疾病风险增加。在英国,人们对微生物群进行了研究,以了解它在各种疾病中的作用,如肥胖、糖尿病、炎症性肠病、癌症和精神健康。研究结果表明,通过饮食干预、益生菌、益生元或粪便微生物群移植来调节微生物群可能为预防或治疗这些疾病提供新的策略。对理论、实践和政策的独特贡献:微生物组生态失调理论、卫生假说理论和微生物群-脑-肠轴理论可用于锚定英国人类微生物组在健康和疾病中的作用的未来研究。研究结果可以投资于基于微生物组的治疗方法的开发,包括粪便微生物群移植(FMT)、工程益生菌和微生物衍生产品。决策者应该为基于微生物组的干预措施建立监管框架,确保其安全性、有效性和可及性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Role of the Human Microbiome in Health and Disease in United Kingdom
Purpose: The aim of the study was to investigate the role of the human microbiome in health and disease in United Kingdom. Methodology: The study adopted a desktop methodology. Desk research refers to secondary data or that which can be collected without fieldwork. Desk research is basically involved in collecting data from existing resources hence it is often considered a low cost technique as compared to field research, as the main cost is involved in executive’s time, telephone charges and directories. Thus, the study relied on already published studies, reports and statistics. This secondary data was easily accessed through the online journals and library Findings: The microbiome influences human health and disease by providing essential functions, such as nutrient metabolism, immune regulation, and protection against pathogens. However, the microbiome can also be disrupted by various factors, such as diet, lifestyle, age, genetics, and infections, leading to dysbiosis and increased risk of diseases. In the United Kingdom, research on the microbiome has been conducted to understand its role in various conditions, such as obesity, diabetes, inflammatory bowel disease, cancer, and mental health. The findings suggest that modulating the microbiome through dietary interventions, probiotics, prebiotics, or fecal microbiota transplantation may offer novel strategies for preventing or treating these diseases. Unique Contribution to Theory, Practice and Policy: Microbiome Dysbiosis Theory, Hygiene Hypothesis Theory and Microbiota-Brain-Gut Axis Theory may be used to anchor future studies on role of the human microbiome in health and disease in United Kingdom. Findings can invest in the development of microbiome-based therapeutics, including fecal microbiota transplantation (FMT), engineered probiotics, and microbial-derived products. Policymakers should establish a regulatory framework for microbiome-based interventions, ensuring their safety, efficacy, and accessibility.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信